These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 15456877)
21. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing. Mole DR; Maxwell PH; Pugh CW; Ratcliffe PJ IUBMB Life; 2001 Jul; 52(1-2):43-7. PubMed ID: 11795592 [TBL] [Abstract][Full Text] [Related]
22. The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activity. Li Z; Wang D; Na X; Schoen SR; Messing EM; Wu G EMBO J; 2003 Apr; 22(8):1857-67. PubMed ID: 12682018 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors. Zimmer M; Doucette D; Siddiqui N; Iliopoulos O Mol Cancer Res; 2004 Feb; 2(2):89-95. PubMed ID: 14985465 [TBL] [Abstract][Full Text] [Related]
24. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex. Miller F; Kentsis A; Osman R; Pan ZQ J Biol Chem; 2005 Mar; 280(9):7985-96. PubMed ID: 15611064 [TBL] [Abstract][Full Text] [Related]
25. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. Tanimoto K; Makino Y; Pereira T; Poellinger L EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113 [TBL] [Abstract][Full Text] [Related]
26. The pVHL-hIF-1 system. A key mediator of oxygen homeostasis. Maxwell PH; Pugh CW; Ratcliffe PJ Adv Exp Med Biol; 2001; 502():365-76. PubMed ID: 11950150 [TBL] [Abstract][Full Text] [Related]
27. The von Hippel-Lindau tumor suppressor protein. Ivan M; Kaelin WG Curr Opin Genet Dev; 2001 Feb; 11(1):27-34. PubMed ID: 11163147 [TBL] [Abstract][Full Text] [Related]
28. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493 [TBL] [Abstract][Full Text] [Related]
29. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Blancher C; Moore JW; Robertson N; Harris AL Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776 [TBL] [Abstract][Full Text] [Related]
30. HIF hydroxylation and the mammalian oxygen-sensing pathway. Safran M; Kaelin WG J Clin Invest; 2003 Mar; 111(6):779-83. PubMed ID: 12639980 [No Abstract] [Full Text] [Related]
31. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression. Jensen RL; Gillespie D; House P; Layfield L; Shelton C J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285 [TBL] [Abstract][Full Text] [Related]
32. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma. Turcotte S; Desrosiers RR; Beliveau R Am J Physiol Renal Physiol; 2004 Feb; 286(2):F338-48. PubMed ID: 14583436 [TBL] [Abstract][Full Text] [Related]
33. Tid-1 interacts with the von Hippel-Lindau protein and modulates angiogenesis by destabilization of HIF-1alpha. Bae MK; Jeong JW; Kim SH; Kim SY; Kang HJ; Kim DM; Bae SK; Yun I; Trentin GA; Rozakis-Adcock M; Kim KW Cancer Res; 2005 Apr; 65(7):2520-5. PubMed ID: 15805242 [TBL] [Abstract][Full Text] [Related]
34. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Jaakkola P; Mole DR; Tian YM; Wilson MI; Gielbert J; Gaskell SJ; von Kriegsheim A; Hebestreit HF; Mukherji M; Schofield CJ; Maxwell PH; Pugh CW; Ratcliffe PJ Science; 2001 Apr; 292(5516):468-72. PubMed ID: 11292861 [TBL] [Abstract][Full Text] [Related]
35. Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein. Corn PG; McDonald ER; Herman JG; El-Deiry WS Nat Genet; 2003 Nov; 35(3):229-37. PubMed ID: 14556007 [TBL] [Abstract][Full Text] [Related]
36. The HIF pathway: implications for patterns of gene expression in cancer. Wykoff CC; Pugh CW; Harris AL; Maxwell PH; Ratcliffe PJ Novartis Found Symp; 2001; 240():212-25; discussion 225-31. PubMed ID: 11727931 [TBL] [Abstract][Full Text] [Related]
37. Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α. Okumura F; Uematsu K; Byrne SD; Hirano M; Joo-Okumura A; Nishikimi A; Shuin T; Fukui Y; Nakatsukasa K; Kamura T Mol Cell Biol; 2016 Jun; 36(12):1803-17. PubMed ID: 27090638 [TBL] [Abstract][Full Text] [Related]
38. The von Hippel-Lindau tumor suppressor gene and kidney cancer. Kaelin WG Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019 [TBL] [Abstract][Full Text] [Related]
39. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Ohh M; Park CW; Ivan M; Hoffman MA; Kim TY; Huang LE; Pavletich N; Chau V; Kaelin WG Nat Cell Biol; 2000 Jul; 2(7):423-7. PubMed ID: 10878807 [TBL] [Abstract][Full Text] [Related]
40. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation. He Z; Liu S; Guo M; Mao J; Hughson MD Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]